Active Ingredient: OMEPRAZOLE; SODIUM BICARBONATE
Proprietary Name: KONVOMEP
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 2MG/ML;84MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213593
Product Number: 001
Approval Date: Aug 30, 2022
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
